Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$8.91 - $12.35 $11.9 Million - $16.5 Million
-1,340,000 Reduced 55.01%
1,096,000 $13.5 Million
Q3 2022

Nov 14, 2022

SELL
$6.57 - $9.74 $3.21 Million - $4.75 Million
-488,000 Reduced 16.69%
2,436,000 $21.3 Million
Q2 2022

Aug 15, 2022

BUY
$6.36 - $13.08 $5.65 Million - $11.6 Million
888,000 Added 43.61%
2,924,000 $19.1 Million
Q1 2022

May 16, 2022

SELL
$9.45 - $12.85 $2.72 Million - $3.7 Million
-288,000 Reduced 12.39%
2,036,000 $23.4 Million
Q4 2021

Feb 14, 2022

BUY
$10.57 - $13.23 $5.29 Million - $6.62 Million
500,000 Added 27.41%
2,324,000 $26.6 Million
Q3 2021

Nov 15, 2021

BUY
$11.83 - $15.79 $9.75 Million - $13 Million
824,000 Added 82.4%
1,824,000 $22.2 Million
Q2 2021

Aug 16, 2021

BUY
$13.75 - $17.6 $5.01 Million - $6.41 Million
364,000 Added 57.23%
1,000,000 $15.3 Million
Q1 2021

May 17, 2021

BUY
$13.13 - $18.78 $8.35 Million - $11.9 Million
636,000 New
636,000 $10 Million
Q1 2019

May 15, 2019

SELL
$1.19 - $2.92 $3.97 Million - $9.75 Million
-3,338,414 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$2.17 - $3.28 $82,460 - $124,639
38,000 Added 1.15%
3,338,414 $7.65 Million
Q3 2018

Nov 14, 2018

BUY
$2.69 - $3.89 $188,300 - $272,300
70,000 Added 2.17%
3,300,414 $11.1 Million
Q2 2018

Aug 14, 2018

BUY
$2.82 - $4.07 $2.08 Million - $3 Million
738,000 Added 29.61%
3,230,414 $9.63 Million
Q1 2018

May 15, 2018

BUY
$2.67 - $3.53 $4.58 Million - $6.05 Million
1,714,000 Added 220.19%
2,492,414 $8 Million
Q4 2017

Feb 14, 2018

BUY
$2.37 - $4.15 $284,400 - $498,000
120,000 Added 18.23%
778,414 $2.07 Million
Q3 2017

Nov 14, 2017

BUY
$1.63 - $2.41 $1.07 Million - $1.59 Million
658,414
658,414 $1.49 Million

Others Institutions Holding ATEC

About Alphatec Holdings, Inc.


  • Ticker ATEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 104,656,000
  • Market Cap $552M
  • Description
  • Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform designed to reduce the risk of intraoperative nerve injury; Sigma transforaminal lumbar interbody fusion pedic...
More about ATEC
Track This Portfolio

Track Armistice Capital, LLC Portfolio

Follow Armistice Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Armistice Capital, LLC with notifications on news.